Sector: Pharmaceutical, Chemical, Biotech

COVID-19 testing can identify the SARS-CoV-2 virus by reverse transcription polymerase chain reaction (RT-PCR). It is a technique that first uses reverse transcription by the reverse transcriptase to convert the extracted RNA into DNA and then uses PCR to amplify a piece of the resulting DNA by the DNA polymerase, creating enough to be examined in order to determine if it matches the genetic code of SARS-CoV-2. dNTPs and RNase inhibitors in RT-PCR also play important roles in expanding the growing DNA strand with the help of DNA polymerase and inactivating ribonuclease enzymes to prevent RNA degradation.
SMOBIO Technology has the infrastructure to produce high-quality key materials to supply the production of COVID-19 testing reagents.
In addition, SMOBIO Technology is developing a fast molecular-based diagnostic test and antigen rapid Diagnostic tests for COVID-19 in human biological matrices. A serological test to evaluate if people have the immunity for COVID-19 is also developing.